Skip to main content
Fig. 11 | Hereditas

Fig. 11

From: Identification of a five-miRNA signature as a novel potential prognostic biomarker in patients with nasopharyngeal carcinoma

Fig. 11

Prediction of immunotherapy by risk modeling of target genes. A: KM curve of target gene prognostic model in the Imvigor210 dataset. B: ROC curves of the target gene prognostic model in dataset Imvigor210. C: Comparison of immune cell scores between high-risk and low-risk groups in the Imvigor210 dataset. D: Comparison of immune cell scores between high-risk and low-risk groups in the Imvigor210 dataset. E: Comparison of StromalScore, ImmuneScore and ESTIMATEScore between high-risk and low-risk groups in the Imvigor210 dataset. F: Comparison of PDCD1, CTLA4 and IFNG expression between high-risk and low-risk groups in the Imvigor210 dataset. G: Correlation analysis between immune genes and immune cells in the Imvigor210 dataset

Back to article page

Hereditas

ISSN: 1601-5223

Contact us